Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Unichem LaboratoriesNSE:UNICHEMLAB +0.41%72 Shiller PE Ratio is 27.69 as of Sep. 05, 2026, which is 11% below its 10-year median of 31.15. GuruFocus rates NSE:UNICHEMLAB with a GF Score™ of 72/100 and a GF Value™ of ₹711.46 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 525 Drug Manufacturers companies, Unichem Laboratories ranks worse than 56.38% on this metric.
The historical rank and industry rank for Unichem Laboratories's Shiller PE Ratio or its related term are showing as below:
NSE:UNICHEMLAB'
s Shiller PE Ratio Range Over the Past 10 Years
Min: 14.33 Med: 31.15 Max: 57.73
Current: 27.56
During the past years, Unichem Laboratories's highest Shiller PE Ratio was 57.73. The lowest was 14.33. And the median was 31.15.
NSE:UNICHEMLAB's Shiller PE Ratio is ranked worse than 56.38% of 525
companies
in the Drug Manufacturers industry
Industry Median: 25.41
vs NSE:UNICHEMLAB: 27.56
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
Unichem Laboratories's adjusted earnings per share data for the three months ended in Jun. 2026 was ₹5.890. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₹19.87 for the trailing ten years ended in Jun. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
Unichem Laboratories (NSE:UNICHEMLAB) Shiller PE Ratio Explanation
Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.
Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.
Be Aware
Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.
Unichem Laboratories Shiller PE Ratio Related Terms
Unichem Laboratories Shiller PE Ratio Historical Data
* Premium members only.
The historical data trend for Unichem Laboratories's Shiller PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:UNICHEMLAB vs ZTS: Shiller PE Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Unichem Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Unichem Laboratories Shiller PE Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Unichem Laboratories's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where Unichem Laboratories's Shiller PE Ratio falls into.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Add all the adjusted EPS together and divide 10 will get our E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Unichem Laboratories (NSE:UNICHEMLAB) has a Shiller PE Ratio of 27.69 as of Sep. 05, 2026. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on Unichem Laboratories and its competitors. This is 11% below median its historical median of 31.15. Over the past decade, Unichem Laboratories' Shiller PE Ratio has ranged from 14.33 to 57.73. According to the industry distribution chart, Unichem Laboratories ranks #296 out of 525 companies in the Drug Manufacturers industry, placing it in the top 56.4%.
Is Unichem Laboratories' Shiller PE Ratio too high?
Unichem Laboratories' current Shiller PE Ratio of 27.69 is 11% below median its 10-year median of 31.15. Over the past 10 years, this metric has ranged from a low of 14.33 to a high of 57.73. The Drug Manufacturers industry median Shiller PE Ratio is 25.41. Unichem Laboratories' value of 27.69 is 9% above this industry median. Based on the distribution chart, Unichem Laboratories ranks #296 out of 525 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Unichem Laboratories has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Unichem Laboratories' Shiller PE Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Unichem Laboratories ranks #296 out of 525 companies for Shiller PE Ratio. This places Unichem Laboratories in the lower half of its industry. The industry median Shiller PE Ratio is 25.41. Unichem Laboratories' value of 27.69 is 9% above this benchmark. Historically, Unichem Laboratories' own Shiller PE Ratio has ranged from 14.33 to 57.73 over the past decade. While the company's 10-year median is 31.15 vs. the industry median of 25.41, Unichem Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shiller PE Ratio for a Drug Manufacturers company?
The median Shiller PE Ratio among Drug Manufacturers companies is 25.41, based on 525 companies in the industry. Companies in the top quartile (top 25%) have a Shiller PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Shiller PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Unichem Laboratories's current Shiller PE Ratio of 27.69 is 9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shiller PE Ratio mean?
A high Shiller PE Ratio can signal that a stock is expensive relative to its fundamentals. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on Unichem Laboratories and its competitors. For the Drug Manufacturers industry, the median Shiller PE Ratio is 25.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Unichem Laboratories's current Shiller PE Ratio is 27.69, which is 11% below median its own 10-year median of 31.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unichem Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Unichem Laboratories (NSE:UNICHEMLAB) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹711.46, compared to a current price of ₹550.20 — trading 22.7% below its estimated fair value. The current Shiller PE Ratio is 27.69, which is 11% below median its 10-year median of 31.15 and 9% above the Drug Manufacturers industry median of 25.41. Unichem Laboratories' overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shiller PE Ratio calculated?
Shiller PE Ratio is calculated from a company's financial statements. For Unichem Laboratories (NSE:UNICHEMLAB), the current Shiller PE Ratio is 27.69 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Unichem Laboratories (NSE:UNICHEMLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Unichem Laboratories stock appears to be undervalued.
The current stock price of ₹550.20 is trading 22.7% below its estimated GF Value™ of ₹711.46.
GuruFocus considers Unichem Laboratories to be Modestly Undervalued.
Key valuation signals for NSE:UNICHEMLAB:
Shiller PE Ratio: 27.69 (11% below median its 10-year median of 31.15)
GF Value™: ₹711.46 vs. price of ₹550.20 (22.7% below fair value)
Industry Position: 9% above the Drug Manufacturers median (#296 of 525)
No single metric tells the full story. See the NSE:UNICHEMLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.
72GF Score
Get the complete analysis for NSE:UNICHEMLAB
Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:UNICHEMLAB has been successfully added to your 
